81
Participants
Start Date
July 10, 2014
Primary Completion Date
November 30, 2017
Study Completion Date
November 30, 2017
EkoSonic® Endovascular System
Alteplase
Recombinant tissue plasminogen activator
NYU Langone Medical Center, New York
Weill Cornell Medical Center, New York
Christiana Hospital, Newark
Inova Alexandria Hospital, Alexandria
Sentara Norfolk General Hospital, Norfolk
Piedmont Atlanta Hospital, Atlanta
Medical Center of Central Georgia, Macon
Tampa General Hospital, Tampa
University of Louisville Research Foundation, Louisville
Fairfield Medical Center, Lancaster
Aultman Hospital, Canton
University of Michigan Medical Center, Ann Arbor
CHI Health St. Elizabeth, Lincoln
Ochsner Medical Center, New Orleans
DFW Vascular Group/ Methodist Dallas Medical Ctr, Dallas
Houston Methodist Sugar Land Hospital, Sugar Land
University of Colorado Hospital, Aurora
UCLA Medical Center, Los Angeles
Oregon Health & Science University, Portland
Vascular Breakthroughs, Darien
Maine Medical Center, Portland
Holy Name Medical Center, Teaneck
Lead Sponsor
Collaborators (1)
EKOS Corporation
INDUSTRY
Boston Scientific Corporation
INDUSTRY